TAVR (TAVI)

Video

ISMICS 2026 | How to Do It Movie Session, Part 2

July 27, 2026 | Tomas Holubec…

This video completes a day of excellent presentations by leading surgeons exploring advanced minimally invasive techniques including congenital ventricular septal defect (VSD) surgery, endoscopic transcatheter aortic valve replacement (TAVR) explantation, multivessel minimally invasive direct coronary...

Video

THVGreece 2026 | Tricuspid Valve

August 6, 2026 | Evangelos Leontiadis…

This session features leading surgeons discussing the tricuspid valve at the Transcatheter Heart Valves Greece (THVGreece) 2026 conference. Moderators Vassilis Voudris, Director of the Cardiology/Interventional Cardiology Division, Onassis Cardiac Surgery...

Podcast

The Atrium: Aortic Valve Replacement

July 28, 2026 | Alice CopperwheatBronze Contributor…

In this episode of The Atrium, host Dr. Alice Copperwheat speaks with Dr. Filip Casselman, Staff Surgeon and Co-Director of the Cardiovascular Center at OLV Clinic (AZORG), Aalst, Belgium, about...

Video

ISMICS 2026 | How to Do It Movie Session, Part 2

July 27, 2026 | Tomas Holubec…

This video completes a day of excellent presentations by leading surgeons exploring advanced minimally invasive techniques including congenital ventricular septal defect (VSD) surgery, endoscopic transcatheter aortic valve replacement (TAVR) explantation,...

Video

The TAVR Heart Team at Risk: An Interview With Michael Mack and Tom Nguyen

July 23, 2026 | Michael Mack…

CTSNet Editor-in-Chief Joel Dunning speaks with Drs. Michael Mack and Tom Nguyen about the proposed US Centers for Medicare & Medicaid Services changes to how cardiologists and cardiac surgeons interact...

JANS Article

Transcatheter vs. Surgical Aortic Valve Replacement in Women: The RHEIA Trial

May 1, 2025 | Mateo Marin-Cuartas

Women with severe symptomatic aortic stenosis are underrepresented in clinical trials. The Randomized Research in Women All Comers with Aortic Stenosis (RHEIA) trial investigates the balance of benefits and risks...

JANS Article

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

April 24, 2025 | Mateo Marin-Cuartas

The Evolut Low Risk trial demonstrated that transcatheter aortic valve replacement (TAVR) was noninferior to surgery for the primary endpoint of all-cause mortality or disabling stroke at two years. In...

JANS Article

Dealing With the Aortic Annulus: Surgical Aortic Annulus Enlargement With a Balloon Catheter

January 9, 2025 | Andre Tyszka

The treatment of aortic valve disease has evolved, and it is expected that TAVR will be available to most patients in the next few years. However, TAVR with a bioprosthesis...

JANS Article

Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Isolated Redo Surgical Aortic Valve Replacement

November 26, 2024 | Jessica Luc

This study compared outcomes between patients undergoing valve-in-valve transcatheter aortic valve replacement (ViV TAVR) and redo surgical aortic valve replacement (redo SAVR) using a retrospective analysis of institutional databases, which...

JANS Article

Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis—EARLY TAVR Trial

November 26, 2024 | Mateo Marin-Cuartas

The EARLY TAVR trial investigators randomly assigned patients with asymptomatic severe aortic stenosis to undergo either early transfemoral transcatheter aortic valve replacement (TAVR) or clinical surveillance. The primary end point...

JANS Article

Initial Experience With Transcatheter Aortic Valve Replacement Before and After Lung Transplant

October 31, 2024 | Mujtaba MubashirGold Contributor

The role of transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis in the pre- and post-lung transplant population is limited. This specific patient population is considered high...

JANS Article

The Perceval Sutureless Bioprosthetic Aortic Valve: Evolution of Surgical Valve Technology

October 3, 2024 | Jessica Luc

Aortic stenosis affects more than 9 million people worldwide and is commonly treated with surgical aortic valve replacement (SAVR), which is known for producing excellent long-term outcomes. Recent advancements in...

JANS Article

Long Term Durability of Bioprosthetic Aortic Valve Replacement in Young Patients With Bicuspid Aortic Stenosis

August 8, 2024 | Mujtaba MubashirGold Contributor

Treatment of aortic stenosis due to a bicuspid aortic valve (BAV), requires a lifetime strategy due to structural valve degeneration that necessitates redo intervention, such as surgical aortic valve replacement...

LOAD MORE
ADVERTISE ON CTSNET